MYC and lung carcinoma: miR-1827 was recently reported to target L-MYC, and a nucleotide polymorphism for the miR-1827 binding site in the L-MYC3′-UTR is associated with an increased risk for lung cancer, indicating an important role for miR-1827 in suppressing lung cancer18.